Journal for ImmunoTherapy of Cancer Impact Factor, Quartile, Indexing, Ranking

Journal for ImmunoTherapy of Cancer (JIC) is a scholarly journal dedicated to publishing research in the field of Pharmacology, Toxicology and Pharmaceutics, and Published by BMJ. The Print-ISSN of Journal for ImmunoTherapy of Cancer is 2051-1426 and its abbreviation is J Immunother Cancer.

The Publicaiton fees (APC) is 2885 USD.

The Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the Society for Immunotherapy of Cancer (SITC). The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding among the many stakeholders in this rapidly evolving field. Topics of interest range widely across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.

• Journal Website
• PubMed
• Scopus
• SCImago